AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iLIVER Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Commentary | Open Access

Treatment for unresectable hepatocellular carcinoma patients: Options and management after complete response

Jin-Ming WangaGuo-Gao QiuaZhi-Dong LiuaJia-Yong SuaDa-Long YangaZhu-Jian DengaZhi-Cheng LibJian-Hong Zhonga( )
Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China
Department of General of Surgery, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530021, Guangxi, China
Show Author Information

References

【1】
【1】
 
 
iLIVER
Article number: 100145

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Wang J-M, Qiu G-G, Liu Z-D, et al. Treatment for unresectable hepatocellular carcinoma patients: Options and management after complete response. iLIVER, 2025, 4(1): 100145. https://doi.org/10.1016/j.iliver.2025.100145

441

Views

3

Crossref

3

Scopus

Received: 24 January 2025
Accepted: 06 February 2025
Published: 13 February 2025
© 2025 The Author(s). Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).